Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancer.

Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancer.

Item
http://www.wikidata.org/entity/Q43502471
Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature.Brain metastasis: clinical characteristics, pathological findings and molecular subtyping for therapeutic implications.Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patientsPersonalizing health care: feasibility and future implications.Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase.Prognostic Factors of Survival among Women with Metastatic Breast Cancer and Impact of Primary or Secondary Nature of Disease on Survival: A French Population-Based Study.Molecular subtyping of brain metastases and implications for therapy.Molecular spectrum of somatic EGFR and KRAS gene mutations in non small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel variations in Indian patients.Somatic mutation analysis of KRAS, BRAF, HER2 and PTEN in EGFR mutation-negative non-small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel deletion in HER2 gene from Indian patients.In a cohort of breast cancer screened patients the proportion of HER2 positive cases is lower than that earlier reported and pathological characteristics differ between HER2 3+ and HER2 2+/Her2 amplified cases.
P2860

Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancer.

Item
http://www.wikidata.org/entity/Q43502471
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Impact of HER-2-targeted thera ...... tive metastatic breast cancer.
@en
Impact of HER-2-targeted thera ...... tive metastatic breast cancer.
@nl
type
label
Impact of HER-2-targeted thera ...... tive metastatic breast cancer.
@en
Impact of HER-2-targeted thera ...... tive metastatic breast cancer.
@nl
prefLabel
Impact of HER-2-targeted thera ...... tive metastatic breast cancer.
@en
Impact of HER-2-targeted thera ...... tive metastatic breast cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Impact of HER-2-targeted thera ...... itive metastatic breast cancer
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698